| Abstrakt: |
Turnover of noradrenaline in various regions of the rat brain was estimated by the decrease in noradrenaline content and/or formaldehyde-induced catecholamine fluorescence after inhibition of noradrenaline biosynthesis with α-methyl-p-tyrosine. Clonidine (0.1 and 0.3 mg/kg p.o.) decelerated the decrease in noradrenaline content of the locus coeruleus, the nucleus of the solitary tract, the intermediolateral cell column and the ventral horn of the thoracic spinal cord, as measured in tissue punches of the respective regions with a sensitive radioenzymatic method. In all these central regions the clonidine-induced decrease in noradrenaline turnover was antagonized by yohimbine, but not by phenoxybenzamine, indicating mediation through central α-adrenoceptors, similar to the cardiovascular effects clonidine. When given alone, both yohimbine and phenoxybenzamine accelerated the disappearance of noradrenaline after inhibition of its biosynthesis. The combined results of radioenzymatic assay and fluorescence histochemistry determinations demonstrated that clonidine markedly reduced noradrenaline turnover in central noradrenaline-containing nerve terminals, but had no effect on the cell bodies of the A and A cell groups. Noradrenaline turnover was, however, decreased in projection areas of the A and A cell groups, namely the intermediolateral cell column of the spinal cord and nucleus of the solitary tract, respectively. This observation argues against the existence of a neuronal feedback loop running from the projection areas to the cell bodies of the A and A cell groups and mediating inhibition of noradrenaline turnover. The effect of clonidine on noradrenaline turnover is, therefore, most likely the result of a local feedback inhibition through presynaptic α-adrenoceptors. Since the nucleus of the solitary tract and the intermediolateral cell column of the spinal cord are prime candidates for the site of the cardiovascular action of clonidine and since the cardiovascular effects of clonidine can be elicited in the virtual absence of neuronal noradrenaline (Haeusler 1974), the present results suggest that the decrease in central noradrenaline turnover and the cardiovascular effects of clonidine are not interrelated phenomena. [ABSTRACT FROM AUTHOR] |
Full text from SpringerLink